Skip to main content

Education

  • Can.med., University of Oslo (professional study in medicine)

Position

  • PhD fellow, Department of Rheumatology, Outpatient Clinic and Research, Diakonhjemmet Hospital

Field of interest

  • Rheumatology
  • Immunosuppressive medications
  • Personalized medicine
  • Therapeutic drug monitoring
  • Immunogenicity
  • Randomized controlled trials

Email

This email address is protected from spambots. You need JavaScript enabled to view it.

Telephone

Visiting address

Diakonhjemmet Hospital
Superintendent's residence
Reidar Kobros vei 8
0370 Oslo

Postal address

Diakohjemmet Hospital
PO Box 23 Vinderen
0319 Oslo

Projects

WP2 - PPhenotyping for personalized medicine

NOR DRUM

The Norwegian study for therapeutic pharmacovigilance

WP1 - Optimized medical interventions

SQUEEZE

Maximizing the effectiveness of prescription drugs for rheumatoid arthritis 


Publications

Publications retrieved from the National Science Archives (NVA):

Cost-effectiveness of proactive therapeutic drug monitoring of maintenance infliximab treatment in patients with immune-mediated inflammatory diseases: results from a randomized controlled trial

2026

Cost-effectiveness of proactive therapeutic drug monitoring of maintenance infliximab treatment in patients with immune-mediated inflammatory diseases: results from a randomized controlled trial - PubMed

2026

Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyzes of the randomised, controlled NOR-DRUM trials

2024

PhD dissertations

2024

HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases

2023

Assessing Immunogenicity of Biologic Drugs in Inflammatory Joint Diseases: Progress Towards Personalized Medicine

2022

Risk factors for anti-drug antibody formation to infliximab: Secondary analyzes of a randomized controlled trial

2022

Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial

2021

Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial

2021

Compulsory medication in mental health care – a systematic literature review

2017